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Abstract Avoidance of facial nerve palsy is one of the
major goals of vestibular schwannoma (VS) microsurgery.
In this study, we examined the significance of previously
implicated prognostic factors (age, tumor size, the extent of
resection and the surgical approach) on post-operative
facial nerve function. We selected all VS patients from
prospectively collected database (1984–2009) who under-
went microsurgical resection as their initial treatment for
histopathologically confirmed VS. The effect of variables
such as surgical approach, tumor size, patient age and
extent of resection on rates facial nerve dysfunction after
surgery, were analyzed using multivariate logistic regres-
sion. Patients with preoperative facial nerve dysfunction
(House-Brackman [HB] score 3 or higher) were excluded,
and HB grade of 1 or 2 at the last follow-up visit was
defined as ‘‘facial nerve preservation.’’ A total of 624 VS
patients were included in this study. Multivariate logistic
regression analysis found that only pre-operative tumor
size significantly predicted poorer facial nerve outcome for
patients followed-up for C6 and C12 months (OR 1.27,
95% CI 1.09–1.49, p \ 0.01; OR 1.35, 95% CI 1.10–1.67,
P \ 0.01, respectively). We found no significant relation-
ship between facial nerve function and age, extent of
resection, surgical approach, or tumor size (when extent of
resection and surgical approach were included in the
regression analysis). Because facial nerve palsy is a
debilitating and psychologically devastating condition for
the patient, we suggest altering surgical aggressiveness in
patients with unfavorable tumor anatomy, particularly in
cases with large tumors where overaggressive resection
might subject the patient to unwarranted risk. Residual
disease can be followed and controlled with radiosurgery if
interval growth is noted.
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Introduction
Vestibular schwannoma (VS) is a benign tumor that arises
from one or more constituent nerves comprising the eighth
cranial nerve complex [1, 2]. Attempts at surgical removal
of these tumors can be complicated by intraoperative
damage to the facial nerve and the cochlear nerve, along
with other neurological and vascular injuries [1, 3–13].
Even though advances in surgical techniques have
improved facial nerve outcomes, functional preservation is
still an issue because injury to the facial nerve has signif-
icant physical and psychological consequences for the
patient [14–16]. It has been suggested that age, tumor size,
and surgical approach all can impact ultimate facial func-
tional outcome [16–19].
There are a number of studies in the literature that
present the outcome of facial nerve function after VS
resection; however, these studies largely are small to
modest sized case series [12]. In this study, we prospec-
tively collected facial nerve function data on 624 patients
over a course of 25 years. We examined the significance of
previously implicated prognostic factors (age, tumor size,
the extent of resection and the surgical approach) on the
rates of post-operative facial nerve preservation.
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Methods
Patient population
Clinical, radiographic and audiometric data for all patients
evaluated and/or treated for a known or presumed VS by
the senior authors (Lawrence H. Pitts and Andrew T. Parsa)
at our institution over a 25 year period (1984–2009) were
prospectively collected in a database. We retrospectively
identified all patients in this database with data relevant to
this study undergoing microsurgical resection of VS.
Patients with a history of prior microsurgery for VS, or
radiosurgery/radiotherapy were excluded. Also, any patient
who did not have 6 months of follow-up, including early
post-operative death, were excluded from analysis. This
study was conducted with the approval of the University of
California at San Francisco Committee on Human
Research under approval number H41995-32911-01.
Data analysis
Patient data were collected prospectively. In all cases,
intraoperative direct stimulation of the tumor surface,
monitored by facial EMG, was used to identify the facial
nerve position and function prior to any tumor manipula-
tion and resection. Permanent facial nerve dysfunction was
defined as House-Brackman (HB) grade 3 or higher func-
tion persisting for greater than 6 months beyond the date of
surgery [20].
Tumor size was measured as the largest single pre-
operative tumor diameter including the intracanalicular
portion. The extent of resection was judged by subjective
intraoperative impression; however, if an MRI performed
within 6 months of surgery demonstrated that this
impression was wrong, the extent of resection classification
was reclassified to correlate to the MRI findings. Near total
resection (NTR) indicates that only of a thin layer of tumor
remained on one or more nerves in a conscious attempt to
preserve function. If imaging studies revealed gross evi-
dence of residual disease, then it was termed subtotal
resection (STR).
Statistical analysis
In this study, we assessed the relationship between per-
manent facial nerve palsy and age, tumor size, the extent of
resection and the surgical approach. Binary variables were
compared using Pearson’s v2 test. Continuous variables
were compared using an independent samples t-test or
ANOVA.
Given statistically significant between group differences
in potentially confounding variables, such as tumor size,
we performed multivariate regression analysis to study the
impact of tumor size, extent of resection, and surgical
approach on facial nerve function. Variables which
impacted facial nerve outcome with a P = 0.2 or less on
univariate analysis were included in stepwise binary
logistic regression modeling [21]. All odds ratios on mul-
tivariate analysis, reflect the risk of having facial nerve
palsy at 6 month post-operatively. The goodness of fit of
the regression model was confirmed by demonstrating a
non-significant P-value on the Hosmer–Lemeshow test [21,
22].
We tested interaction terms between each of the three
variables to significantly impact hearing on univariate
analysis. The statistical significance of the interactions was
assessed with the use of backward stepwise regression, in
which statistical significance was estimated by means of
the likelihood-ratio test to assess the effect of removing
interaction terms for all strata of the given variable [21].
After finding that none of the interaction terms would
significantly (unadjusted P [ 0.2 for all terms) alter the
log likelihood of the regression model if removed, we
calculated the adjusted odds ratios without adjusting for
interactions for C6 months follow-up and C12 months
follow-up.
Continuous variables are presented as mean ± SE.
Statistical tests were considered significant when the two
sided P \ 0.05 after correcting for multiple comparisons
using the Bonferroni method. All statistical tests were
performed using SPSS version 17.
Results
Patient population
A total of 624 patients underwent microsurgical resection for
acoustic neuroma in this period. About 255 (41%) patients
had facial nerve palsy (HB grade 3 or higher) and 369 (59%)
patients had normal facial function (HB grade 1 or 2)
6 months post-operatively. The demographic characteristics
of these two groups are compared in Table 1. We also
present surgeon comparison which shows insignificant
relationship to facial nerve preservation (57 vs. 62%,
P = 0.196; Table 2). The median follow-up for these
patients was 37 months, with 64% patients followed
C12 months, 37% patients followed up for [60 months and
14% of patients followed for [120 months.
The effect of patient age on facial nerve preservation
The mean patient age was 49.5 years (range 13–80 years) in
our study. There was no statistical difference between a
patient’s age and facial nerve preservation (49 ± 0.79 years
for facial palsy vs. 49 ± 0.65 years for normal facial
282 J Neurooncol (2011) 102:281–286
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function, P = NS; Table 1), and this remained an insignif-
icant predictor of outcome in the multivariate model
(Table 3).
The effect of size on facial nerve preservation
As expected, the mean tumor size was higher for patients
with post-operative facial nerve palsy than for those with
normal facial nerve functioning (2.5 ± 0.07 cm vs.
1.9 ± 0.06 cm, respectively, P \ 0.0001; Table 1). Given
that there was a statistically significant difference in tumor
size between patients who had facial nerve palsy and those
with normal facial nerve function, we performed univariate
analysis based on three ranges for tumor sizes (Table 2).
On multivariate analysis, tumor size predicted facial nerve
palsy even when extent of resection and surgical approach
were included in the regression model for patients followed
C6 and C12 months (OR 1.27, 95% CI 1.09–1.49,
P \ 0.01; OR 1.35, 95% CI 1.10–1.67, P \ 0.01; Table 3a
and b, respectively).
The effect of extent of resection on facial nerve
preservation
Gross total resection (GTR) was performed in 455 (73%) of
624 patients, NTR was performed in 76 patients (12%), and
STR was performed in 93 patients (15%). There was no
statistical difference (P = 0.171) between extent of
resection and facial nerve preservation (Table 1) on uni-
variate analysis, and NTR and STR did not alter facial
nerve outcomes when tumor size was included in the
multivariate regression model for patients followed C6 and
C 12 months. Similarly, GTR was not associated with
increased facial nerve palsy when controlling for tumor
size.
The effect of surgical approach on facial nerve
preservation
The middle cranial fossa approach was performed in 136
(22%) of 624 patients, the retrosigmoid approach was
performed in 161 patients (26%), and the translabyrinthine
approach was performed in 327 patients (52%). There was
no statistically significant relationship (P = 0.010)
between the surgical approach and facial nerve palsy on
either univariate (Table 1) or multivariate analysis for
patients followed C6 and C12 months.
The learning curve of facial nerve preservation
Table 4 depicts facial nerve preservation rates as a function
of year of neurosurgeon experience. As seen in Table 4,
that while between-year rates of facial nerve palsy vary
significantly, in general, facial nerve preservation were
lower in the first 2 years of VS surgical practice, and
improved slightly over time.
Discussion
The risk of facial nerve palsy after microsurgical removal
of VS cannot be entirely eliminated, even with refinements
in surgical technique. Thus, surgical resection of these
Table 1 Clinical characteristics of patients in this series
N = 624 Facial nerve palsy P-value
Yes No
255 (%) 369 (%)
Gender NS
Male 116 (45) 176 (47)
Female 139 (55) 196 (53)
Age (years) 49 ± 0.79 49 ± 0.65 NS
Tumor size (cm) 2.5 ± 0.07 1.9 ± 0.06 \0.0001*
Extent of resection 0.171
Gross total resection 176 (39) 279 (61)
Near total resection 37 (49) 39 (51)
Subtotal resection 42 (45) 51 (55)
Approach \0.011*
Middle cranial fossa 45 (33) 91 (67)
Retrosigmoid 58 (36) 103 (64)
Translabyrinthine 152 (46) 175 (54)
Cyst NS
Yes 21 (41) 30 (59)
No 234 (41) 339 (59)
Neurofibromatosis-2 (NF2) NS
Yes 15 (50) 15 (50)
No 240 (40) 354 (60)
* P \ 0.05, NS not significant
Table 2 Results of univariate analysis demonstrating the effect of
tumor size and surgeon on facial nerve palsy
N = 624 Facial nerve palsy
Yes (%) No (%)
Extracanalicular tumor diameter (cm)
B1.0 24 76
1.1–2.0 37 63
2.1–3.0 48 52
[3.0 56 44
Surgeon
1 43 57
2 38 62
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tumors is associated with significant risk of physical, cos-
metic, and psychological morbidity associated with sig-
nificant facial nerve palsy [8, 23]. Previously, in a
systematic review of the literature, we focused on factors
associated with reported rates of facial nerve function in a
large population of 11,873 patients treated VS, and found
that patients with larger tumors were less likely to have
preserved facial nerve function after surgery than patients
with smaller tumors (B2.0 cm 90% vs. [2.0 cm 67%,
P \ 0.0001) [12].
In this study, we examined facial nerve function in 624
patients undergoing VS surgery at our institution and found
that tumor size is the most important predictor of facial nerve
outcome, and that age, extent of resection and surgical
approach do not independently predict facial palsy. This
finding replicates the results of our previous systemic review.
The facial nerve can usually tolerate a large degree of
stretching, compression or distortion without apparent
facial palsy [19, 24]. However, as the tumor grows, the
nerve comes under even greater tension, which increases
the likelihood of stretch injury, and this may explain the
high rate of facial palsy seen in patients with large tumors
[19, 24]. Facial nerve dysfunction may also result from poor
vascularization of nerve segments that are effaced by large
tumors [19, 24]. While larger tumors pose greater risk to the
nerve; however, tumor size alone cannot predict the degree
of adhesiveness, or the difficulty of dissection [18, 19],
suggesting that other factors also impact facial nerve out-
come. The facial nerve can traverse any part of the tumor
capsule and even pass through the tumor itself, a feature that
occurs equally in small and large tumors [15]. Thus, addi-
tional methods for pre-operative assessment of these
patients may be needed to improve surgical outcomes.
The lack of benefit we observed with less aggressive
resection deserves additional discussion. Our STRs were
not planned, and it is interesting to speculate that an
approach of intentional STR might be warranted in many
Table 3 (a) Results of the
multivariate analysis
demonstrating the odds ratio
and confidence intervals for rate
of facial nerve palsy when
tumor size, extent of resection
and surgical approach are
included in the regression model
facial outcomes at 6 months and
(b) multivariate analysis limited
to facial outcome at 12 months
OR Facial nerve palsy 95% CI P-value
– ?
(a) C 6 months follow-up (N = 624)
Tumor size (cm)
Per 0.1 cm 1.27 1.09 1.49 \0.01
Extent of resection
Near Total resection 1.23 0.71 2.17 0.70
Subtotal resection 1.05 0.66 1.67 1.19
Surgical approach
Retrosigmoid 0.80 0.66 1.14 0.19
Translabyrinthine 1.04 0.66 1.64 1.14
(b) C 12 months follow-up (N = 400)
Tumor size (cm)
Per 0.1 cm 1.35 1.10 1.67 \0.01
Surgical approach
Retrosigmoid 0.93 0.63 1.36 0.705
Translabyrinthine 0.79 0.55 1.15 0.223
Table 4 Facial nerve outcomes expressed as a function of years of
surgeon experience
Surgeon year n Percentage facial
nerve preservation
1 16 50
2 25 52
3 20 60
4 12 50
5 9 44
6 20 70
7 24 71
8 26 77
9 29 66
10 30 57
11 30 63
12 22 45
13 40 45
14 45 62
15 43 56
16 45 51
17 47 53
18 51 63
19 36 64
20 31 71
21 23 65
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cases. The concept of intentional STR or STR based on
intra-operative findings might represent the future of VS
surgery, and is certainly worthy of further study. The cases
that were subtotal or NTR relate to factors such as thinning
of the facial nerve or adherent vessel loops that preclude
safe removal of tumor. Thus, while our data do not prove
hypothesis that STR of large VS is superior to GTR, our
consideration of these findings have changed our practice,
and led us to plan STR’s in more difficult cases, stopping
earlier, and treating the residual fragment with radiosurgery
post-operatively. Time will tell whether this is the best way
to improve facial nerve outcomes in these patients.
Further, while there may be a small difference in facial
nerve outcomes between patients receiving GTR and STR,
our analysis suggests that it may take a large study to dem-
onstrate this benefit. We performed a power analysis and
found that to demonstrate the 8% between group difference
demonstrated in this study with 80% power and a = 0.05
would require 454 patients per group. We think such an effort
would take several centers many years to demonstrate.
In conclusion, because facial palsy is a debilitating and
psychologically devastating condition for the patient, we
suggest altering surgical aggressiveness in patients with
unfavorable tumor anatomy, particularly in cases with large
tumors. It has been shown in the literature that neuro-
monitoring during VS resection can be an effective
approach to preserve facial nerve function, although it has
limited ability to predict the extent or rate of recovery in
cases of abnormal function [14, 25–28]. With large tumors,
residual disease can be followed and controlled with radi-
osurgery if interval growth is noted [3, 15].
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